Trial Information

Summary: A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Status: Recruiting

Protocol Number: DECREASE-VI

Sponsor:

Company Division: Diagnostic

Official Scientific Title: A prospective study to assess the screening value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for the identification of patients that benefit from additional cardiac testing prior to vascular surgery.

Brief Summary: The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.

Study Phase: N/A

Study Design / Study Details:

• Purpose:
• Allocation: Non-Randomized
• Masking: Open Label
• Control: Historical
• Assignment: Parallel
• Endpoints:

Study Type:

Condition: Peripheral Vascular Disease

Intervention Type: Diagnostic Test

Intervention Name: ELECSYS®proBNP

Primary Outcome:

Key Secondary Outcomes:

Inclusion Criteria:

Exclusion Criteria:

Gender: Males or Females

Age Limits: Min: 18 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: February, 2007

Trial Registration Date: 08/21/2007

Date Last Updated: 08/28/2007

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: August 20, 2008 at 2:14:31 PM